Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$PIII P3 Health Partners Announces First-Quarter 2023 Results
-Capitated revenue increases 11% vs. the same period in the prior year
-Q1 2023 operating loss improved 7% vs. the same period in the prior year
-Q1 2023 medical margin improvement of 58% vs. the same period in the prior year
-Increases Adjusted EBITDA guidance
Management to Host Conference Call and Webcast May 10, 2023 at 4:30 PM ET
https://finance.yahoo.com/news/p3-health-partners-announces-first-200500156.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$PIII News after the close: P3 Health Partners Announces First-Quarter 2023 Results
News Link:
https://www.businesswire.com/news/home/20230510005748/en/P3-Health-Partners-Announces-First-Quarter-2023-Results#:~:text=First%2DQuarter%202023%20Financial%20Results&text=Net%20loss%20was%20%2452.4%20million,quarter%20of%20the%20prior%20year.
$PIII plans to release its financial results for first-quarter 2023 and file its quarterly report on Form 10-Q on Wednesday, May 10, 2023. In connection with this release, management will host a conference call and webcast to provide a corporate and financial update:
Title & Webcast
P3 Health First-Quarter 2023 Earnings Conference Call
Date & Time
May 10, 2023, 4:30pm Eastern Time
Conference Call Details
Toll-Free 1-877-270-2148 (US)
International 1-412-902-6510
Ask to be joined into the P3 Health Partners call
The conference call will also be webcast live in the "Events & Presentations" section of the Investor page of the P3 website (ir.p3hp.org). The Company’s press release will be available on the Investor page of P3’s website in advance of the conference call. An archived recording of the webcast will be available on the Investor page of P3’s website for a period of 90 days following the conference call.
$PIII care team creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. For more information, visit www.p3hp.org
$PIII has an expansive network of more than 2,500 affiliated primary care providers across the country.
$PIII The Company is a leading population health management company committed to transforming healthcare by improving the lives of both patients and providers.
Nice volume and price action so far this morning... UP 5%.
$PIII
I definitely think that there's much more upside here...
$PIII
Yes, I've noticed that. Looks like we might have an opportunity to load cheaper shares.
Very interested to see their results.
$PIII
I don't think you missed it. This stock should triple from here.
A lot of profit taking going on now. There will be volatility as we get closer to the EPS report on May 10.
Try to get some on the BID and some on the ASK...
$PIII
I missed the boat on this one. I received a very strong insider buy signal but I didn't see it for over 2 weeks.
Pacific Founders Ugp ....Chicago
"INSIDER 4/6/23 BUY $5.5 M at $1.18"
Nice volume and price action the past few days...
$PIII
Holy smokes, it's trading nearly 21x its 10-day average volume in Power Hour... UP almost 44%!
$PIII
$PIII $2.54 +55.00% on NEWS -P3 Health Partners Schedules First-Quarter 2023 Earnings Release and Conference Call https://finance.yahoo.com/news/p3-health-partners-schedules-first-120000491.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
Nice to see these two highlights from that News.
*Affirming 2023 guidance – introducing year-end medical margin guidance
*Anticipates reaching Adjusted EBITDA positive in early 2024
$PIII
Looking forward to hearing more about the P3 Health First-Quarter 2023 Financials, and possibly some other updates too.
$PIII
NEWS: $PIII P3 Health Partners Schedules First-Quarter 2023 Earnings Release and Conference Call https://finance.yahoo.com/news/p3-health-partners-schedules-first-120000491.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
P3 Health Partners Schedules First-Quarter 2023 Earnings Release and Conference Call
8:00 am ET May 2, 2023 (BusinessWire)
P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for first-quarter 2023 and file its quarterly report on Form 10-Q on Wednesday, May 10, 2023. In connection with this release, management will host a conference call and webcast to provide a corporate and financial update:
Title & Webcast P3 Health First-Quarter 2023 Earnings Conference Call
------------------------ ------------------------------------------------------
Date & Time May 10, 2023, 4:30pm Eastern Time
------------------------ ------------------------------------------------------
Conference Call Details Toll-Free 1-877-270-2148 (US)
International 1-412-902-6510
Ask to be joined into the P3 Health Partners call
------------------------ ------------------------------------------------------
About P3 Health Partners (NASDAQ: PIII):
P3 Health Partners Inc. is a leading population health management company committed to transforming healthcare by improving the lives of both patients and providers. Founded and led by physicians, P3 has an expansive network of more than 2,800 affiliated primary care providers across the country. Our local teams of health care professionals manage the care of thousands of patients in 15 counties across five states. P3 supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, the P3 care team creates an enhanced patient experience by navigating, coordinating, and integrating the patient's care within the healthcare system. For more information, visit www.p3hp.org and follow us on LinkedIn and Facebook.com/p3healthpartners
View source version on businesswire.com: https://www.businesswire.com/news/home/20230502005292/en/
SOURCE: P3 Health Partners Inc.
Kassi Belz, Executive Vice President Communications
P3 Health Partners
(904) 415-2744
kbelz@p3hp.org
Investor Relations
Karen Blomquist
Vice President, Investor Relations
P3 Health Partners
kblomquist@p3hp.org
$PIII Affirming 2023 guidance – introducing year-end medical margin guidance
Anticipates reaching Adjusted EBITDA positive in early 2024 as P3 Health Partners Announces Fourth Quarter and Full-Year 2022 Results https://finance.yahoo.com/news/p3-health-partners-announces-fourth-111100677.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
Looking forward to hearing more from the company on the details below.
Through a deal with our largest shareholder Chicago Pacific Founders and other shareholders including Leavitt Partners, we have secured approximately $90 million in funding to an equity agreement. We are grateful for the support and the confidence of our shareholders Chicago Pacific Founders, Leavitt Partners and other shareholders as well. The capital that we raised will provide us the financial resources to realize our strategic vision for P3. And we believe and we will address the details of the capital raise tool, Kavthekar our CFO will address those calculations that is sufficient to get us through to cash flow positive and profitability in 2024.
$PIII
$PIII "In 2022, our medical margin which represents the amount earned from capitation revenue after medical claims expenses are deducted, improved 429% over the prior year to $62 million or $52 on a PMPM basis, network contribution which we define as medical margin less network expenses, improved by 65% over the year to a loss of $7.7 million, where we believe that the trends in these two critical data points are proof that our model is working."
$PIII Q4 2022 Earnings Call Transcript: https://finance.yahoo.com/news/p3-health-partners-inc-nasdaq-145222168.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
Trading only 25% of its 10-day average volume as we close out lunchtime...but UP almost 8% and at the high of the day on the ASK.
$PIII
Nice volume and price action today...
$PIII
For full-year 2023, the Company’s preliminary guidance is as follows:
At-risk Medicare Advantage membership is expected to be in a range of 115,000 to 120,000
Revenue is expected to be in a range of $1.20 billion to $1.25 billion
The Company expects that 2023 Adjusted EBITDA loss will be between $40 million and $60 million.
The Company anticipates that its Adjusted EBITDA will be positive in 2024.
$PIII
$PIII Reaffirms growth over 61 percent and path to profitability.
https://seekingalpha.com/article/4580482-p3-health-partners-reaffirms-2022-growth-over-61-percent-and-path-to-profitability
$PIII P3 Health Partners Reaffirms Guidance For 2022 and Announces Guidance For 2023 https://finance.yahoo.com/news/p3-health-partners-reaffirms-guidance-210100498.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
Trading nearly half of its 10-day average volume in Power Hour...UP almost 4% and at the high of the day! A new high of the day on the ASK.
$PIII
That's alright because it's trading at $1.15...
$PIII
P3 Health Partners Inc (PIII) PT Lowered to $9 at Lake Street Capital Markets
https://www.streetinsider.com/dr/news.php?id=21456282
$PIII P3 Health Partners Inc. (NASDAQ:PIII) Q4 2022 Earnings Call Transcript https://finance.yahoo.com/news/p3-health-partners-inc-nasdaq-145222168.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
Thank you for that information.
Thank you for sharing that
PIII / P3 Health Partners Inc - Class A - Forecast and Price Target
https://fintel.io/sfo/us/piii
Trading 75% of its 10-day average volume as Power Hour approaches...UP almost 5% and near the high of the day!
$PIII
Yesterday's volume was the highest since the end of June 2022. Nice to see some accumulation, next comes price.
$PIII
Trading 33% over its 10-day average volume as Power Hour starts... some nice buying, UP almost 13% and at the high of the day!
$PIII
Very nice... P3 Health Partners’ guidance breaks the billion-dollar mark in 2022 revenues.
$PIII
This report on Seeking Alpha is exactly what is happening at P3 now and is why shares are about to start back up now. https://seekingalpha.com/article/4580482-p3-health-partners-reaffirms-2022-growth-over-61-percent-and-path-to-profitability
$PIII P3 Health Partners Reaffirms 2022 Growth Over 61% And Path To Profitability https://seekingalpha.com/article/4580482-p3-health-partners-reaffirms-2022-growth-over-61-percent-and-path-to-profitability
Very nice, thank you for sharing that link to the research report...
$PIII
Followers
|
2
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
108
|
Created
|
02/17/23
|
Type
|
Free
|
Moderators |
We support healthier patients and communities.
P3 is a leader in population health management because we embrace a care model and patient support team that is effective in:
P3 Health Partners is a population health management company that supports providers with administrative services and care coordination for Medicare Advantage patients. P3’s model aggregates and supports the community’s existing healthcare resources to build a strong network of community providers working together to deliver highly coordinated and integrated care to our patients with a shared commitment to improving patient outcomes, lowering cost, and delivering a better experience for all.
Founded and led by physicians, our team of healthcare providers and service professionals share a revolutionary vision for delivering patient care with passion and purpose.
Our leadership team consists of experienced healthcare professionals driven by a desire to change the healthcare industry for the better and improve the lives of patients and providers.
Our promise is to guide our communities to better health, enable providers to do the work they love, and enrich the health and quality of life for patients.
As 20-year veterans in population health management, we understand the unique challenges that come with providing value-based care. That’s why we’ve made it our mission to embrace a care model that gives patients the tools and resources they need to better manage their long-term wellness and allow providers the support they need to spend more time with patients and less time on administrative tasks and between-visit care.
For Fiscal Year Ending Dec 31, 2022
3Q 2023 Financial Results
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |